Acurx Pharmaceuticals
ACXP
ACXP
30 hedge funds and large institutions have $1.3M invested in Acurx Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 2 closing their positions.
Holders
30
Holders Change
+6
Holders Change %
+25%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
8
Increased
8
Reduced
8
Closed
2
Calls
$33K
Puts
$29K
Net Calls
+$4K
Net Calls Change
-$1K
Top Buyers
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| $2.12K | 4,155 | -256 | -6% |
|
27
Bank of America
Charlotte,
North Carolina
| $689 | 1,350 | +1,209 | +857% |
|
|
SFA
28
Semmax Financial Advisors
Winston Salem,
North Carolina
| $684 | 153 | -5,487 | -97% |
|
29
BlackRock
New York
| $615 | 1,204 | -33,041 | -96% |
|
|
SS
30
SBI Securities
Tokyo,
Japan
| $145 | 284 | – | – |
|
|
CPG
31
Cornerstone Planning Group
Fairfield,
New Jersey
| – | – | -3,344 | Closed |
|
32
JPMorgan Chase & Co
New York
| – | – | -29 | Closed |
|
33
Citadel Advisors
Miami,
Florida
| – | – | – | – |
|